Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CANRENONE Cause Hyperkalaemia? 68 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 68 reports of Hyperkalaemia have been filed in association with CANRENONE. This represents 23.8% of all adverse event reports for CANRENONE.

68
Reports of Hyperkalaemia with CANRENONE
23.8%
of all CANRENONE reports
0
Deaths
50
Hospitalizations

How Dangerous Is Hyperkalaemia From CANRENONE?

Of the 68 reports, 50 (73.5%) required hospitalization, and 5 (7.4%) were considered life-threatening.

Is Hyperkalaemia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CANRENONE. However, 68 reports have been filed with the FAERS database.

What Other Side Effects Does CANRENONE Cause?

Hyponatraemia (35) Hypotension (33) Sopor (25) Dehydration (24) Syncope (23) Drug interaction (21) Bradycardia (19) Drug ineffective (19) Renal failure (19) Asthenia (18)

What Other Drugs Cause Hyperkalaemia?

METFORMIN (2,565) SPIRONOLACTONE (2,518) FUROSEMIDE (2,035) RAMIPRIL (1,383) SACUBITRIL\VALSARTAN (1,192) SULFAMETHOXAZOLE\TRIMETHOPRIM (1,036) LISINOPRIL (948) POTASSIUM (944) BISOPROLOL (850) TACROLIMUS (713)

Which CANRENONE Alternatives Have Lower Hyperkalaemia Risk?

CANRENONE vs CANTHARIDIN CANRENONE vs CAPECITABINE CANRENONE vs CAPIVASERTIB CANRENONE vs CAPLACIZUMAB CANRENONE vs CAPLACIZUMAB-YHDP

Related Pages

CANRENONE Full Profile All Hyperkalaemia Reports All Drugs Causing Hyperkalaemia CANRENONE Demographics